Novo Nordisk shares slide after guidance disappoints investors
CNBC Stocks· Aug 4, 2026 · 6:08 PM
Novo Nordisk raised its financial outlook as it tries to catch up with rival Eli Lilly in the booming GLP-1 market.
This is a summary. Read the complete story at CNBC Stocks below.
Read full article at CNBC StocksRelated Stories
stocksabout 6 hours ago
Exclusive-Anthropic considers releasing new AI model ahead of IPO, sources say
Investing.com
stocksabout 7 hours ago
Morgan Stanley private credit fund redemption requests remain elevated in third quarter
Investing.com
stocksabout 7 hours ago
Gemini hacked three companies in first known breakout by Google’s AI
Investing.com